Recent News

• 02.26.2025 - ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results
• 02.14.2025 - ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025
• 02.12.2025 - ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula
• 01.27.2025 - ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0
• 11.13.2024 - ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain

Recent Filings

• 02.26.2025 - EX-99.1 EX-99.1
• 02.26.2025 - 8-K Current report
• 02.26.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.29.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.03.2025 - 4 Statement of changes in beneficial ownership of securities